The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Structure Therapeutics Inc ADR (NASDAQ: GPCR) closed at $21.03 down -11.51% from its previous closing price of $23.76. In other words, the price has decreased by -$11.51 from its previous closing price. On the day, 0.64 million shares were traded.
Ratios:
For a deeper understanding of Structure Therapeutics Inc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.63 and its Current Ratio is at 27.63. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
On December 04, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.
On September 23, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $118.Morgan Stanley initiated its Overweight rating on September 23, 2024, with a $118 target price.
Stock Price History:
Over the past 52 weeks, GPCR has reached a high of $62.74, while it has fallen to a 52-week low of $22.33. The 50-Day Moving Average of the stock is -24.23%, while the 200-Day Moving Average is calculated to be -42.04%.
Shares Statistics:
A total of 57.25M shares are outstanding, with a floating share count of 54.44M. Insiders hold about 4.91% of the company’s shares, while institutions hold 102.85% stake in the company.
Earnings Estimates
The dynamic stock of Structure Therapeutics Inc ADR (GPCR) is currently being evaluated by a team of 8.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.18 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$0.65 and -$0.88 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.71, with 9.0 analysts recommending between $1.94 and -$1.41.
